Table 1.
MUC3a | N | p-value | ||
---|---|---|---|---|
low | high | |||
Gender | ||||
Male | 38 | 13 | 51 | 0.300 |
Female | 35 | 6 | 41 | |
73 | 19 | |||
Age | ||||
≤ 60 | 37 | 1 | 38 | 0.000 |
> 60 | 36 | 18 | 54 | |
Tumor size (cm) | ||||
< 4 | 33 | 12 | 45 | 0.623 |
≥ 4 | 23 | 11 | 34 | |
None | 7 | 6 | ||
Histological grade | ||||
I/I-II | 5 | 2 | 7 | 0.039 |
II | 43 | 7 | 50 | |
II-III/III | 22 | 9 | 31 | |
I-III | 3 | 1 | 4 | |
Clinical Stage | ||||
I | 20 | 3 | 23 | 0.045 |
II | 15 | 3 | 18 | |
III-IV | 18 | 8 | 26 | |
Non | 18 | 7 | 25 | |
Lymph node status | ||||
< 4 | 23 | 2 | 25 | 0.149 |
≥ 4 | 48 | 12 | 60 | |
Non | 2 | 5 | 7 | |
Carcinoma | ||||
Primary | 73 | 19 | 92 | |
Adjacent | 89 | 0 | 89 | |
ALK | 67 | 17 | 84 | 0.111 |
positive | 61 | 13 | 74 | |
negative | 6 | 4 | 10 | |
Non | 6 | 2 | 8 | |
EGFR | 73 | 19 | 92 | 0.553 |
positive | 17 | 4 | 21 | |
negative | 56 | 15 | 71 |